The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Krishna Ella said
Ninety-six countries have agreed to mutual recognition of COVID-19 vaccination certificates with India, Union Health Minister Mansukh Mandaviya said on Tuesday.
India must speed up vaccination
The apex court had earlier in August asked the Centre, Bharat Biotech, SII, and others to respond to the plea which sought directions to also disclose post-vaccination data regarding adverse events
People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study
Germany's coronavirus infection rate climbed to its highest recorded level yet on Monday as what officials have called a pandemic of the unvaccinated gathers pace
The coronavirus pandemic had prompted the US to close its borders to international travellers from many countries, including India, last year
Party passes resolution saying it would achieve victory in all forthcoming state elections
JAB AT HAND: From encouraging people to volunteer to screening kids and winning their confidence
More than 116.50 crore Covid vaccine doses have been provided to states and Union territories so far through the Centre and direct state procurement category, the Union health ministry said on Friday.
More than 15.54 crore balance and unutilized Covid-19 vaccine doses are still available with the states and UTs to be administered, said Union Health Ministry on Friday
Biotechnology firm Novavax Inc said it has completed the rolling submission for the emergency use listing (EUL) of its COVID-19 vaccine candidate to the World Health Organization (WHO). Earlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisation (EUA) for COVID-19 vaccine in Indonesia. "The company has now completed the submission to World Health Organization (WHO) of all modules required for the regulatory evaluation of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M adjuvant," Novavax Inc said in a statement on Thursday. The chemistry, manufacturing and controls module submitted to WHO, as well as other regulatory agencies worldwide, leverages Novavax' manufacturing partnership with the SII, the world's largest vaccine manufacturer by volume, it added. Novavax will make further submissions to enable vaccine supply from additional manufacturing sites
Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab
Covaxin gets the stamp of international legitimacy
The previous goal had eyed vaccinating 70 per cent of the world's population by the autumn of 2022
The home secretary said states and union territories, on a regular basis, should closely monitor case positivity, hospital, ICU beds occupancy of every district falling under their jurisdiction
Intentions to buy consumer products through Nykaa and Croma picked up pace
The technical advisory group will now meet on November 3 for a final assessment.
India's Covid-19 vaccination coverage has crossed 103 crore with over 51 lakh vaccine doses administered on Tuesday, the Union health ministry said
International business travel remains limited and is unlikely to get back to the pre-covid levels for some time yet